RMD Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 18:00):

Stats
Šios dienos apimtis	277 461
Vidutinė apimtis	1.11M
Rinkos kapitalizacija	31.52B
EPS	$0 ( 2024-04-25 )
Kita pelno data	( $2.01 ) 2024-08-01
Last Dividend	$0.480 ( 2023-11-08 )
Next Dividend	$0 ( N/A )
P/E	33.06
ATR14	$0.296 (0.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-29	Burt Carol	Sell	234	ResMed Common Stock
2024-04-29	Drexler Karen	Sell	425	ResMed Common Stock
2024-03-04	Rider Michael J	Sell	81	ResMed Common Stock
2024-03-01	Rider Michael J	Sell	200	ResMed Common Stock
2023-05-03	Farrell Peter C	Sell	12 600	ResMed Common Stock

INSIDER POWER
14.26
Last 97 transactions
Buy: 212 786 \| Sell: 179 948

Tūris Koreliacija

Ilgas: 0.45 (neutral)

Trumpas: -0.70 (moderate negative)

Signal:(54.456) Neutral

Resmed Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Resmed Inc Koreliacija - Valiuta/Žaliavos

0.71
( moderate )

0.40
( neutral )

0.41
( neutral )

0.15
( neutral )

0.75
( moderate )

0.00
( neutral )

Resmed Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$4.22B
Bruto pelnas:	$2.36B (55.78 %)
EPS:	$6.12

FY	2023
Pajamos:	$4.22B
Bruto pelnas:	$2.36B (55.78 %)
EPS:	$6.12

FY	2022
Pajamos:	$3.58B
Bruto pelnas:	$2.02B (56.57 %)
EPS:	$5.34

FY	2021
Pajamos:	$3.20B
Bruto pelnas:	$1.84B (57.53 %)
EPS:	$3.27

Financial Reports:

No articles found.

Resmed Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.440 (N/A)	$0.440 (N/A)	$0.440 (N/A)	$0.440 (N/A)	$0.480 (N/A)	$0.480 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Resmed Inc Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.25 - Increase likely (45.06%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.170	2012-09-05
Last Dividend	$0.480	2023-11-08
Next Dividend	$0	N/A
Payout Date	2023-12-14
Next Payout Date	N/A
# dividends	46	--
Total Paid Out	$15.72	--
Avg. Dividend % Per Year	0.54%	--
Score	4.86	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.25
Div. Directional Score	8.97	--

Next Divdend (Est)
(2024-07-01)

$0.490 Estimate 39.56 %

Dividend Stability

0.79 Good

Dividend Score

4.86

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2012	$0.340	1.33%
2013	$0.840	1.98%
2014	$1.060	2.29%
2015	$1.160	2.03%
2016	$1.260	2.41%
2017	$1.360	2.20%
2018	$1.440	1.68%
2019	$1.520	1.36%
2020	$1.560	1.00%
2021	$1.620	0.76%
2022	$1.720	0.66%
2023	$1.840	0.88%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
ZTR	Dividend Royal	2024-02-09	Monthly	37	8.35%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.216	1.500	5.69	8.53	[0 - 0.5]
returnOnAssetsTTM	0.141	1.200	5.31	6.37	[0 - 0.3]
returnOnEquityTTM	0.219	1.500	8.68	10.00	[0.1 - 1]
payoutRatioTTM	0.288	-1.000	7.12	-7.12	[0 - 1]
currentRatioTTM	3.04	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	1.393	0.800	6.51	5.21	[0.8 - 2.5]
cashRatioTTM	0.308	1.500	9.40	10.00	[0.2 - 2]
debtRatioTTM	0.151	-1.500	7.48	-10.00	[0 - 0.6]
interestCoverageTTM	-22.18	1.000	-9.33	-9.33	[3 - 30]
operatingCashFlowPerShareTTM	8.16	2.00	7.28	10.00	[0 - 30]
freeCashFlowPerShareTTM	7.29	2.00	6.36	10.00	[0 - 20]
debtEquityRatioTTM	0.223	-1.500	9.11	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.573	1.000	3.79	3.79	[0.2 - 0.8]
operatingProfitMarginTTM	0.273	1.000	6.54	6.54	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1.162	1.000	4.65	4.65	[0.2 - 2]
assetTurnoverTTM	0.652	0.800	8.98	7.19	[0.5 - 2]
Total Score				10.68

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	32.97	1.000	6.77	0	[1 - 100]
returnOnEquityTTM	0.219	2.50	9.15	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	7.29	2.00	7.57	10.00	[0 - 30]
dividendYielPercentageTTM	0.874	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.16	2.00	7.28	10.00	[0 - 30]
payoutRatioTTM	0.288	1.500	7.12	-7.12	[0 - 1]
pegRatioTTM	0.630	1.500	9.13	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.270	1.000	5.76	0	[0.1 - 0.5]
Total Score				7.25

Resmed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.